WeVote
Log In

Bill

Bill

HB 524

relative to disbursement of funds by the New Hampshire vaccine association.

2026 Regular Session Introduced by Mike Belcher and 5 co-sponsors

HB 524 alters New Hampshire Vaccine Association fund disbursement procedures and creates a committee to assess the association's effectiveness and operations.

Signed by Governor Ayotte 06/19/2026; Chapter 152; eff.08/18/2026
0
WeVote Research Nonpartisan
Bill Summary · HB 524

Legislative bill overview

HB 524 modifies how the New Hampshire Vaccine Association disburses its funds and establishes a legislative committee to evaluate the association's effectiveness and operational practices. The bill appears designed to increase oversight and scrutiny of vaccine-related fund management and program outcomes.

Why is this important

The New Hampshire Vaccine Association manages significant public health resources and vaccination programs. Changes to fund disbursement mechanisms and formal efficacy reviews could affect vaccine availability, program funding, and public health infrastructure in the state.

Potential points of contention

  • Definition of "efficacy" in review: Disagreement may arise over whether the committee evaluates clinical/epidemiological outcomes, administrative efficiency, or both, reflecting different priorities for vaccine programs
  • Fund disbursement constraints: New restrictions on how funds are allocated could either improve accountability or limit operational flexibility and responsiveness to urgent vaccination needs
  • Committee composition and scope: Questions about whether the study committee includes public health experts, whether findings are binding, and what authority exists to implement recommendations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.